The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
PD-L1 expression and response to immunotherapy in patients with MET exon 14-altered non-small cell lung cancers (NSCLC).
 
Joshua K. Sabari
No Relationships to Disclose
 
Joseph Montecalvo
No Relationships to Disclose
 
Ruqin Chen
Employment - GlaxoSmithKline (I)
Stock and Other Ownership Interests - GlaxoSmithKline; Lilly
 
Jordan A. Dienstag
No Relationships to Disclose
 
Chebli Mrad
No Relationships to Disclose
 
Isabella Bergagnini
No Relationships to Disclose
 
Wei-Chu Victoria Lai
No Relationships to Disclose
 
Kathryn Cecilia Arbour
No Relationships to Disclose
 
Catherine A. Shu
Consulting or Advisory Role - Genentech/Roche
 
Matthew David Hellmann
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Janssen; Merck; Novartis
Research Funding - Bristol-Myers Squibb; Genentech/Roche
 
Gregory J. Riely
Consulting or Advisory Role - Genentech; Novartis; Novartis; Roche
Research Funding - ARIAD (Inst); GlaxoSmithKline (Inst); Infinity Pharmaceuticals (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Novartis
 
Mark G. Kris
Consulting or Advisory Role - ARIAD; AstraZeneca; Genentech/Roche
Research Funding - Genentech/Roche (Inst); Puma Biotechnology (Inst)
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; AVEO; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Merck; Novartis
Research Funding - Biomarin
 
Natasha Rekhtman
No Relationships to Disclose
 
Alexander E. Drilon
Honoraria - AstraZeneca; Blueprint Medicines; Exelixis; Genentech/Roche; Ignyta; Loxo
Consulting or Advisory Role - ARIAD
Research Funding - Foundation Medicine